宫腔灌注改善反复种植失败患者妊娠结局的研究进展  

Research progress on intrauterine perfusion in improving pregnancy outcome in patients with repeated implantation failure

作　　者：吕海霞 何玉洁[2] LU Hai-xia;HE Yu-jie(Shanxi Medical University,Taiyuan 030001,China;Department of Reproductive Medicine,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学,山西太原030001 [2]山西医科大学第一医院生殖医学中心,山西太原030001

出　　处：《实用药物与临床》2022年第8期759-764,共6页Practical Pharmacy and Clinical Remedies

摘　　要：胚胎质量及子宫内膜容受性是影响体外受精-胚胎移植结局的主要原因。近年来子宫内膜容受性受到生殖医学专家们的关注。宫腔灌注可作为提高子宫内膜容受性、改善妊娠结局的新治疗方法之一。本文就宫腔灌注药物改善子宫内膜容受性的研究进展进行阐述。Embryo quality and endometrial receptivity are the main factors affecting the outcome of in vitro fertilization embryo transfer.In recent years,endometrial receptivity has attracted attention from reproductive medicine experts.Intrauterine perfusion can be used as one of the new treatment methods to improve endometrial receptivity and pregnancy outcome.This paper reviews the research progress of intrauterine perfusion drugs in improving endometrial receptivity.

关 键 词：体外受精-胚胎移植 反复种植失败 宫腔灌注 子宫内膜容受性 免疫因素 

分 类 号：R714.8[医药卫生—妇产科学]